HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CIR To Re-Review Sunscreen Agents Retinyl Palmitate, Oxybenzone In 2011

This article was originally published in The Rose Sheet

Executive Summary

In light of rekindled controversy, the Cosmetic Ingredient Review Expert Panel plans to consider new safety data for sunscreen ingredients retinyl palmitate and benzophenone-3 (oxybenzone) in 2011

You may also be interested in...



CIR To Reconsider Retinol, Triclosan, Parabens In Light Of New Data

The Cosmetic Ingredient Review Expert Panel will entertain new data regarding the safety of retinol/retinyl palmitate, triclosan and parabens at its next meeting to determine if safety assessments for the ingredients should be re-opened for further review.

EWG’s Sunscreen Recommendations Up From 2010, But Health Concerns Remain

With FDA’s final sunscreen monograph reportedly around the corner, a greater percentage of sunscreens garnered the Environmental Working Group’s approval this year than in past market surveys, but the group still has concerns about sunscreen regulation and ingredient safety.

EWG’s Sunscreen Recommendations Up From 2010, But Health Concerns Remain

With FDA’s final sunscreen monograph reportedly around the corner, a greater percentage of sunscreens garnered the Environmental Working Group’s approval this year than in past market surveys, but the group still has concerns about sunscreen regulation and ingredient safety.

Related Content

UsernamePublicRestriction

Register

RS017169

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel